4.1 Article

Rhabdomyolysis-Induced Acute Kidney Injury (AKI) in a Young Bodybuilder: A Case Report

Journal

CUREUS JOURNAL OF MEDICAL SCIENCE
Volume 15, Issue 2, Pages -

Publisher

CUREUS INC
DOI: 10.7759/cureus.34625

Keywords

nonsteroidal anti-inflammatory drugs; bodybuilding; ibuprofen; rhabdomyolysis; acute kidney injury

Ask authors/readers for more resources

Acute kidney injury (AKI) is a serious condition caused by various factors, including rhabdomyolysis. In this case, a bodybuilder developed rhabdomyolysis-induced AKI after taking Ibuprofen for a fever. Multiple factors, such as muscle trauma, dehydration, infection, and drug toxicity, contributed to the development of AKI. Treatment typically involves aggressive fluid resuscitation, electrolyte replacement, and addressing the underlying cause. Early diagnosis and treatment are crucial for managing AKI successfully.
Acute kidney injury (AKI) is a serious medical condition that can have many causes, including rhabdomyolysis. Rhabdomyolysis is the breakdown of muscle tissue that can lead to the release of muscle fiber contents into the bloodstream. This can cause serious damage to the kidneys, leading to AKI. In this case, a young bodybuilder was diagnosed with rhabdomyolysis induced by AKI after consuming Ibuprofen for a casual fever. The etiology of AKI in rhabdomyolysis is complex, with multiple factors contributing to the development of the condition. These include muscle trauma, dehydration, infection, and drug toxicity. In this case, Ibuprofen may have contributed to the development of AKI, as it can cause kidney damage when taken in large doses. Additionally, the bodybuilder's physical activity may have contributed to the development of rhabdomyolysis, as intense exercise can cause muscle damage. Treatment for AKI in rhabdomyolysis patients typically involves aggressive fluid resuscitation, electrolyte replacement, and dialysis if necessary. Additionally, the underlying cause of the rhabdomyolysis must be identified and treated. In this case, the patient should be monitored closely for any signs of kidney damage, and the Ibuprofen should be discontinued. In conclusion, this is a case of a relatively common presentation with uncommon circumstances. It is crucial to have a heightened understanding of the likelihood of AKI in patients with rhabdomyolysis and the impact of drug toxicity in exacerbating the condition. Early diagnosis and treatment are essential for the successful management of AKI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available